OrbusNeich Medical Group (HKG:6929) reported $41.9 million in attributable profit for 2025, up 5.5% from $39.7 million in 2024, according to a Hong Kong bourse filing Thursday.
Earnings per share was $0.0508, compared with $0.0481 in the prior year.
Revenue increased 10% year on year to $180.5 million, figures showed.
The company also declared a dividend of HK$0.12 per share, payable June 26 to shareholders of record on June 16.